Paclitaxel, cisplatin, and epirubicin first-line chemotherapy in Stage III and IV ovarian carcinoma
Article 2000 en
Authors
CP
C.A. Papadimitriou
LM
Lia A. Moulopoulos
GV
Georgios Vlahos
Abstract
1 min read
The combination of paclitaxel, cisplatin, and epirubicin is a well tolerated outpatient regimen with significant activity in the treatment of advanced epithelial ovarian carcinoma.
Gerasimos Aravantinos, George Fountzilas, Haralabos P. Kalofonos, D. Skarlos, P. Kosmidis, Irene Grimani, Nicholas Pavlidis, D. Bafaloukos, Dimitrios Pectasides, Meletios A Dimopoulos
George Fountzilas, A. Athanassiades, Vaios Papadimitriou, Meletios A Dimopoulos, D. Bafaloukos, Gerasimos Aravantinos, C. Nicolaides, Haralabos P. Kalofonos, Pavlos Papakostas, Nikolaos I. Xiros, Esma Razi
George Fountzilas, C. Papadimitriou, Gerasimos Aravantinos, C. Nicolaides, G. Stathopoulos, Dimitrios Bafaloukos, Haralabos P. Kalofonos, T. Ekonomopoulos, D. Skarlos, Nicholas Pavlidis, Meletios A Dimopoulos
Christos Papadimitriou, K. Sarris, Lia A. Moulopoulos, George Fountzilas, Athanassios Anagnostopoulos, Zannis Voulgaris, Dimitra Gika, Nikolaos Giannakoulis, Emmanuel Diakomanolis, Meletios A Dimopoulos
Discussion(0)
No comments yet. Be the first to comment.